- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Severe/Very Severe COVID-19 Illness in India
Total 11 results
-
NMC Specialty HospitalCompletedThrombosis | COVID-19 Pneumonia | Severe Acute Respiratory Syndrome (SARS) Pneumonia | COVID-19 Acute Respiratory Distress SyndromeIndia
-
Bharat Biotech International LimitedIndian Council of Medical Research; Iqvia Pty LtdActive, not recruitingCovid19 | SARS-CoV InfectionIndia
-
University of SheffieldChristian Medical College, Vellore, IndiaRecruitingFever | Typhoid | Paratyphoid Fever | Acute Febrile Illness | Enteric FeverIndia
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
University of OxfordBill and Melinda Gates Foundation; Department for International Development... and other collaboratorsRecruitingSevere Acute Respiratory SyndromeGhana, Indonesia, Nepal, South Africa, United Kingdom, Vietnam, India
-
Ascend Performance MaterialsJehangir Clinical Development Centre Pvt. Ltd.RecruitingInfluenza -Like Illness | SARS CoV-2 InfectionIndia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
Foundation for Innovative New Diagnostics, SwitzerlandIndian Council of Medical Research; University of Oxford; WHO, Special Programme...CompletedAcute Febrile IllnessUganda, Burkina Faso, Ghana, India, Nepal
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Population Health Research InstituteBayerCompletedSevere Acute Respiratory Syndrome | CoronavirusEgypt, Canada, Brazil, Colombia, Ecuador, India, Nepal, Pakistan, Philippines, Russian Federation, South Africa, United Arab Emirates
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland